Patents by Inventor William G. Tucker

William G. Tucker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and methods for treating cancer and viral infections
    Patent number: 8916605
    Abstract: The present application relates to the use of one or more compounds of Formula (I) or pharmaceutically acceptable solvates or prodrugs thereof, for treating cancer or for treating or preventing a viral infection.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: December 23, 2014
    Inventor: William G. Tucker
  • 6-(Calkylseleno)purines and methods for treating neural measles viral infection therewith
    Patent number: 8552011
    Abstract: The present application relates to anti-viral selenopurine compounds of formula (I): wherein R1 is C2-6alkyl, and pharmaceutically acceptable salts, solvates, and prodrugs thereof. These 6-(C2-6alkylseleno)purine compounds find use in the treatment of neural measles virus infection and associated diseases (namely, multiple sclerosis or neural measles). A particularly preferred compound is ethylselenopurine or ESP.
    Type: Grant
    Filed: June 4, 2009
    Date of Patent: October 8, 2013
    Inventor: William G. Tucker
  • COMPOUNDS AND METHODS FOR TREATING CANCER AND VIRAL INFECTIONS
    Publication number: 20120035238
    Abstract: The present application relates to the use of one or more compounds of Formula (I) or pharmaceutically acceptable solvates or prodrugs thereof, for treating cancer or for treating or preventing a viral infection.
    Type: Application
    Filed: March 2, 2010
    Publication date: February 9, 2012
    Applicant: GOFF HILL LIMITED
    Inventor: William G. Tucker
  • 6-(C2-6ALKYLSELENO)PURINES AND METHODS FOR TREATING NEURAL MEASLES VIRAL INFECTION THEREWITH
    Publication number: 20110086867
    Abstract: The present application relates to anti-viral selenopurine compounds of formula (I): wherein R1 is C2-6alkyl, and pharmaceutically acceptable salts, solvates, and prodrugs thereof. These 6-(C2-6alkylseleno)purine compounds find use in the treatment of neural measles virus infection and associated diseases (namely, multiple sclerosis or neural measles). A particularly preferred compound is ethylselenopurine or ESP.
    Type: Application
    Filed: June 4, 2009
    Publication date: April 14, 2011
    Inventor: William G. Tucker